PT  - JOURNAL ARTICLE
AU  - Jacyna, Garry
AU  - Thompson, James R.
AU  - Koehler, Matt
AU  - Slater, David M.
TI  - Analytical Model of COVID-19 for lifting non-pharmaceutical interventions
AID  - 10.1101/2020.07.31.20166025
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.31.20166025
4099  - http://medrxiv.org/content/early/2020/08/04/2020.07.31.20166025.short
4100  - http://medrxiv.org/content/early/2020/08/04/2020.07.31.20166025.full
AB  - In the present work, we outline a set of coarse-grain analytical models that can be used by decision-makers to bound the potential impact of the COVID-19 pandemic on specific communities with known or estimated social contact structure and to assess the effects of various non-pharmaceutical interventions on slowing the progression of disease spread. This work provides a multi-dimensional view of the problem by examining steady-state and dynamic disease spread using a network-based approach. In addition, Bayesian-based estimation procedures are used to provide a realistic assessment of the severity of outbreaks based on estimates of the average and instantaneous basic reproduction number R0.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe validation data is publicly available and cited in the paper.